The efficacy and safety of enzalutamide in patients with non-muscle invasive bladder cancer
Phase 2
- Conditions
- non-muscle invasive bladder cancer
- Registration Number
- JPRN-UMIN000026520
- Lead Sponsor
- rology department of Tsukuba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
history of androgen deprivation therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor shrinkage 4 weeks after administration
- Secondary Outcome Measures
Name Time Method safety